Modulating Microbial Behaviors to Treat Skin Disease: ENS-002 in Atopic Dermatitis & 33 Million Data Points for Targeted Microbial Interventions
Time: 10:45 am
day: Day One AM
Details:
- Discover how Concerto’s kChip platform identified ENS‑002 by screening over 5 million microbial combinations
- Highlight the Phase I trial testing ENS‑002’s safety and impact on Staphylococcus aureus in AD patients
- Explore how microbe-based therapies like ENS‑002 can provide long-term relief without the risks of immunosuppression
- Preview the Skin Universe Project’s role in enabling future microbial consortia for other dermatologic conditions
